Study RTD-01 is a non-interventional, pilot study designed to determine if a specific coded SMS text message study tool is effective in collecting daily real time safety data in subjects participating in clinical trials.

This study is to determine if a daily SMS text message study tool will improve adverse event and concomitant medication reporting. Patient reported adverse events and changes in concomitant medications are essential in clinical trials to determine drug-related symptoms and side effects. This study will help identify the benefits and challenges of real time daily reported outcome measures that can later be implemented in future clinical trials to enhance trial outcomes. In addition, data collected from this study will support a more sophisticated safety study tool for future study participants.

Inclusion Criteria:

• 18-85 age inclusive
• Male or Female
• Currently enrolled in an ongoing clinical trial
• Capable of providing informed consent and complying with daily study procedures
• Must be able to receive and respond to text messages through phone provider

Exclusion Criteria:

• Subjects not currently involved in a clinical trial
• Subjects who cannot receive text messages
• Unable to comply to the study protocol and study visits

-Men and women from 18-85 years of age inclusive, who are currently enrolled in a clinical trial at Perseverance Research Center. All subjects must meet all inclusion and no exclusion criteria to be eligible for enrollment.